Related Experiment Videos
[Modification of complement components under the effect of cationic proteins from leukocytes from donors and leukemia
Insights
Leukocyte cation proteins (CP) modify complement C3. In healthy individuals, CP reduce C3 levels, while in leukemia patients, they increase C3 fragments, potentially lowering immune resistance.
Area of Science:
- Immunology
- Biochemistry
Context:
- Leukocytes are key immune cells.
- The complement system, particularly C3, plays a vital role in innate immunity.
- Leukocyte-derived proteins can influence immune responses.
Purpose:
- To investigate the in vitro effect of leukocyte-derived cation proteins (CP) on the C3 component of the complement system.
- To compare the effects of CP from healthy individuals versus patients with chronic leukemia.
Summary:
- Cation proteins (CP) were isolated from leukocytes using ion exchange chromatography.
- Enzyme immunoassay revealed that CP modify complement C3.
- CP from healthy volunteers decreased C3 levels in purified and serum samples, without altering C3.H2O or C3a-fragment.
- CP from chronic myeloleukemia and chronic lympholeukemia patients showed a less distinct effect on C3.
- CP from myeloleukemia patients increased C3b-like form, while CP from lympholeukemia patients increased C3a-fragment.
Impact:
- Leukemia-associated CP may alter complement C3 processing differently than in healthy individuals.
- Increased C3 fragments in leukemia could potentially reduce the body's non-specific resistance.
- This research sheds light on the immunomodulatory role of leukocyte cation proteins in health and disease.
Abstract:
Cation proteins (CP) were isolated from leukocytes by means of ion exchange chromatography. Enzyme immunoassay showed that these cation proteins modified C3 component of complement in vitro. CP obtained from healthy volunteers decreased the content of C3 purified by affinity chromatography and C3 of blood serum; however, content of C3.H2O op C3b-like form and C3a-fragment were not altered. Effect of CP isolated from leukocytes of patients with chronic myeloleukemia and chronic lympholeukemia on C3 component was less distinct as compared with that of healthy volunteers. At the same time, content of C3b-like form was increased the presence of CP from patients with myeloleukemia and of C3a-fragment--in the presence of the proteins from patients with lympholeukemia. Excess of physiologically active C3 fragments, developed under conditions of these diseases, may contribute to a decrease in unspecific body resistance.